1. Home
  2. MREO vs RXT Comparison

MREO vs RXT Comparison

Compare MREO & RXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • RXT
  • Stock Information
  • Founded
  • MREO 2015
  • RXT 1998
  • Country
  • MREO United Kingdom
  • RXT United States
  • Employees
  • MREO N/A
  • RXT N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • RXT EDP Services
  • Sector
  • MREO Health Care
  • RXT Technology
  • Exchange
  • MREO Nasdaq
  • RXT Nasdaq
  • Market Cap
  • MREO 281.6M
  • RXT 280.1M
  • IPO Year
  • MREO N/A
  • RXT 2020
  • Fundamental
  • Price
  • MREO $1.76
  • RXT $1.38
  • Analyst Decision
  • MREO Strong Buy
  • RXT Hold
  • Analyst Count
  • MREO 5
  • RXT 5
  • Target Price
  • MREO $7.40
  • RXT $1.58
  • AVG Volume (30 Days)
  • MREO 932.9K
  • RXT 926.8K
  • Earning Date
  • MREO 11-11-2025
  • RXT 11-11-2025
  • Dividend Yield
  • MREO N/A
  • RXT N/A
  • EPS Growth
  • MREO N/A
  • RXT N/A
  • EPS
  • MREO N/A
  • RXT N/A
  • Revenue
  • MREO $500,000.00
  • RXT $2,693,100,000.00
  • Revenue This Year
  • MREO N/A
  • RXT N/A
  • Revenue Next Year
  • MREO $55.50
  • RXT $1.48
  • P/E Ratio
  • MREO N/A
  • RXT N/A
  • Revenue Growth
  • MREO N/A
  • RXT N/A
  • 52 Week Low
  • MREO $1.47
  • RXT $1.00
  • 52 Week High
  • MREO $4.72
  • RXT $3.41
  • Technical
  • Relative Strength Index (RSI)
  • MREO 48.66
  • RXT 52.09
  • Support Level
  • MREO $1.68
  • RXT N/A
  • Resistance Level
  • MREO $1.88
  • RXT $1.52
  • Average True Range (ATR)
  • MREO 0.07
  • RXT 0.09
  • MACD
  • MREO 0.01
  • RXT -0.05
  • Stochastic Oscillator
  • MREO 45.45
  • RXT 90.46

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.

Share on Social Networks: